Latest Myasthenia Gravis news
FDA Approves Zilbrysq for Generalized Myasthenia Gravis
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Thymectomy + PDN Beneficial for Non-Thymomatous Myasthenia Gravis
posted January 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with non-thymomatous myasthenia gravis, thymectomy plus prednisone confers benefits versus prednisone alone at five years, according to a study published online Jan. 25 in The Lancet Neurology.
AI Better Assesses Heart Function From MRI Than Clinicians 
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring 
ED Visits, Hospitalizations for Alcohol, Cannabis Vary by Age 
More Extensive Deposits of Tau Seen in Early-Onset Alzheimer Disease 
Thymectomy Improves Outcomes in Myasthenia Gravis 
Autologous HSCT Can Result in Remission in Myasthenia Gravis Monthly Specialist Briefings
Stay Connected
